Search Results - "Zemlan, Frank"

Refine Results
  1. 1
  2. 2

    A selective dopamine reuptake inhibitor improves prefrontal cortex-dependent cognitive function: Potential relevance to attention deficit hyperactivity disorder by Schmeichel, Brooke E., Zemlan, Frank P., Berridge, Craig W.

    Published in Neuropharmacology (01-01-2013)
    “…Drugs used to treat attention deficit hyperactivity disorder (ADHD) improve prefrontal cortex (PFC)-dependent cognitive function. The majority of ADHD-related…”
    Get full text
    Journal Article
  3. 3

    Oral TNFα Modulation Alters Neutrophil Infiltration, Improves Cognition and Diminishes Tau and Amyloid Pathology in the 3xTgAD Mouse Model by Gabbita, S Prasad, Johnson, Ming F, Kobritz, Naomi, Eslami, Pirooz, Poteshkina, Aleksandra, Varadarajan, Sridhar, Turman, John, Zemlan, Frank, Harris-White, Marni E

    Published in PloS one (05-10-2015)
    “…Cytokines such as TNFα can polarize microglia/macrophages into different neuroinflammatory types. Skewing of the phenotype towards a cytotoxic state is thought…”
    Get full text
    Journal Article
  4. 4

    Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury by Bazarian, Jeffrey J., Zemlan, Frank P., Mookerjee, Sohug, Stigbrand, Torgney

    Published in Brain injury (2006)
    “…Primary objective: To determine the relationship of serum S-100B and C-tau levels to long-term outcome after mild traumatic brain injury (mild TBI). Research…”
    Get full text
    Journal Article
  5. 5

    Serum cleaved tau does not predict postconcussion syndrome after mild traumatic brain injury by Ma, Marek, MD, Lindsell, Christopher J., PhD, Rosenberry, Clark M., BS, Shaw, George J., MD, PhD, Zemlan, Frank P., PhD

    Published in The American journal of emergency medicine (01-09-2008)
    “…Abstract Objectives Our objective was to determine if the biomarker for axonal injury, serum cleaved tau (C-tau), predicts postconcussion syndrome (PCS) in…”
    Get full text
    Journal Article
  6. 6
  7. 7

    C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome by Zemlan, Frank P, Jauch, Edward C, Mulchahey, J.Jeffery, Gabbita, S.Prasad, Rosenberg, William S, Speciale, Samuel G, Zuccarello, Mario

    Published in Brain research (23-08-2002)
    “…Following traumatic brain injury, the neuronally-localized intracellular protein MAP-tau is proteolytically cleaved (C-tau) and gains access to cerebrospinal…”
    Get full text
    Journal Article
  8. 8

    The efficacy and safety of the melatonin agonist β-methyl-6-chloromelatonin in primary insomnia : A randomized, placebo-controlled, crossover clinical trial by ZEMLAN, Frank P, MULCHAHEY, J. Jeffery, SCHARF, Martin B, MAYLEBEN, David W, ROSENBERG, Russell, LANKFORD, Alan

    Published in The journal of clinical psychiatry (01-03-2005)
    “…While melatonin agonists are known to regulate circadian sleep rhythms, it is not clear whether melatonin agonists have a direct soporific effect. It has been…”
    Get full text
    Journal Article
  9. 9

    Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury by Shaw, George J., Jauch, Edward C., Zemlan, Frank P.

    Published in Annals of emergency medicine (01-03-2002)
    “…Study Objective: Intracranial injuries (ICI) are associated with high mortality and morbidity. Unfortunately, tools for diagnosis and risk stratification of…”
    Get full text
    Journal Article
  10. 10

    Quantification of axonal damage in traumatic brain injury : Affinity purification and characterization of cerebrospinal fluid tau proteins by ZEMLAN, F. P, ROSENBERG, W. S, LUEBBE, P. A, CAMPBELL, T. A, DEAN, G. E, WEINER, N. E, COHEN, J. A, RUDICK, R. A, WOO, D

    Published in Journal of neurochemistry (01-02-1999)
    “…Diffuse axonal injury is a primary feature of head trauma and is one of the most frequent causes of mortality and morbidity. Diffuse axonal injury is…”
    Get full text
    Journal Article
  11. 11

    Hypothermia as an adjunctive treatment for severe bacterial meningitis by Irazuzta, Jose E., Pretzlaff, Robert, Rowin, Mark, Milam, Kevin, Zemlan, Frank P., Zingarelli, Basilia

    Published in Brain research (20-10-2000)
    “…Brain injury due to bacterial meningitis results in a high mortality rate and significant neurologic sequelae in survivors. The objective of this study was to…”
    Get full text
    Journal Article
  12. 12

    Serum cleaved Tau protein and neurobehavioral battery of tests as markers of brain injury in experimental bacterial meningitis by Irazuzta, Jose E, de Courten-Myers, Gabrielle, Zemlan, Frank P, Bekkedal, Marni Y.V, Rossi, John

    Published in Brain research (14-09-2001)
    “…Brain injury due to bacterial meningitis affects multiple areas of the brain with a heterogeneous distribution generating a challenge to assess severity. Tau…”
    Get full text
    Journal Article
  13. 13

    Safety, tolerability and pharmacokinetics of 2-pyridylacetic acid, a major metabolite of betahistine, in a phase 1 dose escalation study in subjects with ADHD by Moorthy, Ganesh, Sallee, Floyd, Gabbita, Prasad, Zemlan, Frank, Sallans, Larry, Desai, Pankaj B.

    Published in Biopharmaceutics & drug disposition (01-10-2015)
    “…Betahistine, a potent histamine H3 receptor antagonist, is being developed for the treatment of attention deficit hyperactivity disorder (ADHD) that manifests…”
    Get full text
    Journal Article
  14. 14

    Increased cerebrospinal fluid cleaved tau protein (C-tau) levels suggest axonal damage in pediatric patients with brain tumors by Cengiz, Pelin, Zemlan, Frank, Eickhoff, Jens C., Ellenbogen, Richard, Zimmerman, Jerry J.

    Published in Child's nervous system (01-08-2015)
    “…Objective This study aims to determine if cerebrospinal fluid/serum cleaved tau protein and CSF 9-hydroxyoctadecadienoic acid levels, reflecting potential…”
    Get full text
    Journal Article
  15. 15

    Oral TNF[alpha] Modulation Alters Neutrophil Infiltration, Improves Cognition and Diminishes Tau and Amyloid Pathology in the 3xTgAD Mouse Model by Gabbita, S. Prasad, Johnson, Ming F, Kobritz, Naomi, Eslami, Pirooz, Poteshkina, Aleksandra, Varadarajan, Sridhar, Turman, John, Zemlan, Frank, Harris-White, Marni E

    Published in PloS one (05-10-2015)
    “…Cytokines such as TNF[alpha] can polarize microglia/macrophages into different neuroinflammatory types. Skewing of the phenotype towards a cytotoxic state is…”
    Get full text
    Journal Article
  16. 16

    Quantification of Axonal Damage in Traumatic Brain Injury by Zemlan, Frank, Rosenberg, William S., Luebbe, Patricia A., Campbell, Thomas A., Dean, Gary E., Weiner, Ned E., Cohen, Jeffery A., Rudick, Richard A., Woo, Daniel

    Published in Journal of neurochemistry (01-02-1999)
    “…: Diffuse axonal injury is a primary feature of head trauma and is one of the most frequent causes of mortality and morbidity. Diffuse axonal injury is…”
    Get full text
    Journal Article
  17. 17

    Identification of Microtubule-Associated Protein Tau Isoforms in Alzheimer's Paired Helical Filaments by McLaughlin, Lea, Zemlan, Frank P, Dean, Gary E

    Published in Brain research bulletin (01-01-1997)
    “…AD66 proteins derived from sodium dodecylsulfate (SDS) insoluble paired helical filaments (PHF) were isolated from Alzheimer's brain using a purification…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury by Gabbita, S Prasad, Scheff, Stephen W, Menard, Renee M, Roberts, Kelly, Fugaccia, Isabella, Zemlan, Frank P

    Published in Journal of neurotrauma (01-01-2005)
    “…Previous studies from our laboratory indicate that traumatic brain injury (TBI) in humans results in proteolysis of neuronally-localized, intracellular…”
    Get more information
    Journal Article
  20. 20